CORESTA Meeting, Smoke Science/Product Technology, 2017, Kitzbühel, ST 27
Pharmacokinetics of nicotine following the controlled use of a prototype novel tobacco vapour product
(1) Japan Tobacco Inc., R&D Group, Scientific Product Assessment Center, Yokohama, Kanagawa, Japan; (2) JT International S.A., Scientific & Regulatory Affairs, Geneva, Switzerland
The objective of this clinical study was to investigate the pharmacokinetics of nicotine following the use of a prototype novel tobacco vapour (PNTV) product in comparison to a conventional cigarette (CC1). The study was conducted in Japanese healthy ...